Login / Signup

Immunotherapy in advanced Merkel cell carcinoma: Sydney west cancer network experience.

Shaheen HasmatJulie R HowleDeme J KarikiosMatteo S CarlinoMichael J Veness
Published in: Journal of medical imaging and radiation oncology (2021)
Consistent with clinical trial results, anti-PD-L1/PD1 therapy in this small series demonstrated efficacy and safety in patients with metastatic MCC.
Keyphrases
  • clinical trial
  • papillary thyroid
  • squamous cell
  • open label
  • study protocol
  • phase ii
  • double blind
  • stem cells
  • randomized controlled trial
  • childhood cancer
  • young adults
  • phase iii
  • bone marrow